Press release
Neuropathic Pain Market Intelligence Report Offers Growth Prospects
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also called neuroleptic medications), and antidepressants (also known as tricyclic antidepressants).
Common antidepressants include amitriptyline and nortriptiline whereas valproic acid, carbamazepine, felbamate, phenytoin, and clonazepam a few of the most common anticonvulsants used for the treatment of neuropathic disorders. Tocainide or Mexiletine and Idocaine are some of the major anesthetics used to reduce neuropathic pain.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19871
This report on global neuropathic pain market is a thorough study of the market in its current scenario and based on all the major factors that may impact the growth rate in the near future, it estimates the state of the market until 2024. It also notes and explores some of the trends of the market as well as highlights a few opportunities available. Among the key features of the report is the section on company profiles, wherein several key players in the global market have been analyzed for their product portfolio, market share, global presence, and recent developments including mergers, acquisitions, and collaborations.
The global market for neuropathic pain can be segmented on the basis of drug class, by indication, distribution channel, and region. By drug type, the market can be divided into tricyclic antidepressant, anticonvulsants, local anaesthesia, opioids, steroids, and others. On the basis of indication, the market can be categorized into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and others. By distribution channel, the market can be segmented into retail pharmacies, drug stores, and online pharmacies. Geographically, the report studies the opportunities available in the regions of Asia Pacific, Europe, North America, and Rest of the World.
Global Neuropathic Pain Market: Drivers and Restraints
The report observes that diabetes is the usual indication of neuropathic pain, while cancer comes second. According to the World Health Organization (WHO), 422 million people were suffering from diabetes in 2014 and this number will continue to expand in the near future, especially among the middle to low-income countries. This vast population is the primary driver in the global market. Moreover, rising geriatric population, who commonly suffer from neuropathic pain, is another driver for this market.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=19871
In addition to that, factors such as approval of novel treatment options, increasing demand for neuropathic pain, improving healthcare infrastructure in emerging economies, increased investment by pharmaceutical companies for research and development of improved drugs, and rising number of pain management centers will further fuel the market in positive direction. Conversely, side effects of opioids and steroids as well as cost of branded drugs are some of the factors that will hinder the growth rate of the market during the forecast period.
On the basis of drug class, the segment of anticonvulsants are most popular whereas the demand for tricyclic antidepressant is expected to expand at the best CAGR. By indication, diabetic neuropathy segment serves maximum demand while chemotherapy induced peripheral neuropathy is projected for most prominent growth rate. In terms of distribution channel, retail pharmacies are most profitable and is expected to remain the leading segment during the forecast period.
Global Neuropathic Pain Market: Region-wise Outlook
North America currently is the most lucrative regional market, owing to strong healthcare infrastructure and higher buying ability of the consumers. However, Asia Pacific is projected for the most significant growth rate, due to increasing prevalence of diabetes in countries such as China and India.
Obtain Report Details @ https://www.transparencymarketresearch.com/neuropathic-pain-market.html
Companies mentioned in the research report
Some of the key companies currently operating in global market are Pfizer Inc., Johnson & Johnson Services Inc., Depomed Inc., Bristol-Myers Squibb and Company, Sanofi S.A., Biogen Idec Inc., Eli Lily and Company, GlaxoSmithKline PLC, and Baxter Healthcare Corporation.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Intelligence Report Offers Growth Prospects here
News-ID: 992405 • Views: …
More Releases from Transparency Market Research
Double Glazing Glass Market Set to Reach US$37.8 Billion by 2031 Amid Rising Ado …
The global double glazing glass market, valued at US$23.6 billion in 2022, is poised for robust growth over the next decade. It is estimated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2031, reaching US$37.8 billion by the end of 2031. This strong expansion reflects the increasing demand for energy-efficient building materials, driven by stringent environmental regulations, urbanization, and rising energy costs. As the…
Cyclopentanone Market to Expand at 3.6% CAGR Through 2031 Amid Rising Use in Syn …
The global cyclopentanone market, valued at US$131.9 million in 2022, is set for steady growth over the next decade. It is estimated to grow at a compound annual growth rate (CAGR) of 3.6% from 2023 to 2031, reaching US$180.4 million by the end of 2031. This consistent expansion reflects the increasing demand for cyclopentanone in pharmaceuticals, fragrances, and electronics, driven by sustainability trends, rising consumer spending on personal care, and…
Eco-Friendly Fashion and Automotive Interiors Fuel Growth in Bio-based Leather M …
The global bio-based leather market, valued at US$699.6 million in 2022, is poised for robust growth over the next decade. It is estimated to grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2031, reaching US$1.2 billion by the end of 2031. This strong expansion reflects the rising demand for sustainable alternatives to traditional leather, driven by environmental concerns, consumer preference for eco-friendly materials, and innovations…
Increasing Demand for Decorative and Functional Packaging Fuels Stamping Foils M …
The global stamping foils market, valued at US$1.3 billion in 2022, is poised for steady growth over the next decade. It is estimated to increase at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2031, reaching US$2.4 billion by the end of 2031. This robust expansion reflects the growing demand for stamping foils in packaging, automotive, and consumer goods, driven by aesthetic preferences, branding needs, and advancements…
More Releases for Neuropathic
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Neuropathic Pain Market: Global Industry Demand, Market Future 2028
Neuropathic Pain Market
“Neuropathic Pain-Epidemiology Forecasting Intelligence” report provides a comprehensive analysis of the Neuropathic Pain epidemiology, providing the historical, current, and forecasted data for the United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan during the period from 2018-2028.
Our epidemiology services include:
• Incidence and prevalence
• Diagnosis rate, treatment rate and mortality patterns
• Epidemiology-based forecasting and disease trends
• Size of different patient segments in a…
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.
Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.…
Anticonvulsants for Neuropathic Pain Market unprovoked by 2025
Global Anticonvulsants for Neuropathic Pain Market: Snapshot
Neuropathic pain, which refers to kind of chronic pain resulting from an injury to or disease of the central or peripheral nervous system, remains a therapeutic challenge to clinicians as it does not respond well to conventional pain therapies. Although the clinical knowledge regarding the pathogenesis of the condition has significantly increased over the past few decades, the actual mode of action of most…
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period.
The…
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
